rebamipide

rebamipide   Dan rebamipide

Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: Open label study

Rebamipide is a gastroprotective agent with promising results against gastric damage induced by non-steroidal anti-inflammatory drugs  IndicationsUses Rebamipide is indicated for use as an adjuvant in the treatment of peptic ulcer disease concomitantly with anti-secretory agents including

ตาราง คะแนน ลีก เอิ ง ล่าสุด Rebamipide is a cholecystokinin type 1 receptor inhibitor for inhibiting BH-CCK-8S with IC50 of μM  The invention relates to a rebamipide tablet The rebamipide tablet is prepared from, by weight, 50%-65% of rebamipide, 15%-45% of diluents,